[HTML][HTML] Effects of abiraterone acetate on androgen signaling in castrate-resistant prostate cancer in bone
E Efstathiou, M Titus, D Tsavachidou… - Journal of clinical …, 2012 - ncbi.nlm.nih.gov
Journal of clinical oncology, 2012•ncbi.nlm.nih.gov
Purpose Persistent androgen signaling is implicated in castrate-resistant prostate cancer
(CRPC) progression. This study aimed to evaluate androgen signaling in bone marrow–
infiltrating cancer and testosterone in blood and bone marrow and to correlate with clinical
observations.
(CRPC) progression. This study aimed to evaluate androgen signaling in bone marrow–
infiltrating cancer and testosterone in blood and bone marrow and to correlate with clinical
observations.
Abstract
Purpose
Persistent androgen signaling is implicated in castrate-resistant prostate cancer (CRPC) progression. This study aimed to evaluate androgen signaling in bone marrow–infiltrating cancer and testosterone in blood and bone marrow and to correlate with clinical observations.
ncbi.nlm.nih.gov
